Sara Tabtabai, MD
she/her/hers
Assistant ProfessorCards
About
Research
Publications
2026
Association between Semaglutide 2.4 mg and Risk of Cardiovascular Events in Patients with Heart Failure in the Real-world: Results from the SCORE-HF Study
Smolderen K, Mena-Hurtado C, Divino V, Zhao Z, Chen Y, Boland J, Song J, Iyer P, Knop F, Nanna M, Tabtabai S. Association between Semaglutide 2.4 mg and Risk of Cardiovascular Events in Patients with Heart Failure in the Real-world: Results from the SCORE-HF Study. Journal Of Cardiac Failure - Intersections 2026 DOI: 10.1016/j.yjcafi.2026.05.004.Peer-Reviewed Original ResearchHeart failureLow riskMACE-3Associated with lower riskCardiovascular eventsRisk of cardiovascular eventsOverweight/obesitySecondary outcomesConclusion TreatmentHF managementPrimary outcomeReal-world evidenceRetrospective studyComposite outcomeFollow-upSemaglutideClinical trialsHF outcomesRisk reductionUS databasePatientsOutcomesRiskMACEDiabetesPregnancy-related Heart Failure Readmissions in the US: Analysis of the Nationwide Readmissions Database
Senior author. In review - The Journal of the American Heart AssociationPeer-Reviewed Original ResearchLower Risk of Cardiovascular Events in Patients with Heart Failure Initiated on Semaglutide 2.4 mg in the Real-world: Results from the SCORE-HF Study
Senior author. In Review - JCF Intersections.Peer-Reviewed Original Research26-A-18565-ACC IMPLEMENTATION OF A TRANSNATIONAL PHYSICIAN ELECTROCARDIOGRAM INTERPRETATION PROGRAM TO IMPROVE CARDIOVASCULAR CARE ACCESS IN RURAL JAMAICA
Brown X, Mezue K, ARIZE C, Hibbert R, Dolphin J, Smith P, Kattan C, Tabtabai S, De Freitas C, Miller E, Madu E. 26-A-18565-ACC IMPLEMENTATION OF A TRANSNATIONAL PHYSICIAN ELECTROCARDIOGRAM INTERPRETATION PROGRAM TO IMPROVE CARDIOVASCULAR CARE ACCESS IN RURAL JAMAICA. Journal Of The American College Of Cardiology 2026, 87: a1227. DOI: 10.1016/j.jacc.2026.02.3020.Peer-Reviewed Original Research26-A-17533-ACC ESTIMATES OF JAMAICAN TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) PREVALENCE USING DUAL ARTIFICIAL INTELLIGENCE (AI) ELECTROCARDIOGRAM (ECG) AND ECHOCARDIOGRAM (ECHO) MODELS
Hibbert R, Brown X, ARIZE C, Williams C, De Freitas C, Reid K, Thangaraj P, Adefuye M, Mezue K, Haynes N, Tabtabai S, Kattan C, Oikonomou E, Khera R, Madu E, Miller E. 26-A-17533-ACC ESTIMATES OF JAMAICAN TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) PREVALENCE USING DUAL ARTIFICIAL INTELLIGENCE (AI) ELECTROCARDIOGRAM (ECG) AND ECHOCARDIOGRAM (ECHO) MODELS. Journal Of The American College Of Cardiology 2026, 87: a1226. DOI: 10.1016/j.jacc.2026.02.3017.Peer-Reviewed Original Research26-A-19178-ACC ECHOCARDIOGRAPHIC PHENOTYPING OF AFRO-CARIBBEAN PATIENTS WITH CONGESTIVE HEART FAILURE FROM A JAMAICAN TERTIARY CARE CARDIOLOGY CENTER
Hibbert R, Brown X, ARIZE C, Williams C, De Freitas C, Mezue K, Tabtabai S, Haynes N, Kattan C, Madu E, Miller E. 26-A-19178-ACC ECHOCARDIOGRAPHIC PHENOTYPING OF AFRO-CARIBBEAN PATIENTS WITH CONGESTIVE HEART FAILURE FROM A JAMAICAN TERTIARY CARE CARDIOLOGY CENTER. Journal Of The American College Of Cardiology 2026, 87: a773-a774. DOI: 10.1016/j.jacc.2026.02.1999.Peer-Reviewed Original Research26-CCC-19878-ACC A COMPLEX CASE OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY REQUIRING MULTIPLE ABLATIONS AND HEART TRANSPLANTATION
Adefuye M, Abid S, Safiriyu I, Tabtabai S. 26-CCC-19878-ACC A COMPLEX CASE OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY REQUIRING MULTIPLE ABLATIONS AND HEART TRANSPLANTATION. Journal Of The American College Of Cardiology 2026, 87: a1571-a1572. DOI: 10.1016/j.jacc.2026.02.3935.Peer-Reviewed Original Research
2025
The Effect of a Best Practice Advisory on the Utilization and Impact of Palliative Care Consultation in Heart Failure Hospitalizations
Gooding K, Naraparaju V, Esstman B, Wakefield D, Evjen M, Naseer A, Tabtabai S. The Effect of a Best Practice Advisory on the Utilization and Impact of Palliative Care Consultation in Heart Failure Hospitalizations. Palliative Medicine Reports 2025, 6: pmr.2024.0106. PMID: 40308711, PMCID: PMC12040558, DOI: 10.1089/pmr.2024.0106.Peer-Reviewed Original ResearchPalliative care consultationPalliative care consultation groupLength of stayCare consultationAcute decompensated heart failureImpact of palliative care consultationReadmission ratesBest practice advisoryGoals of carePractice alertMedian length of stayClinician biasPractice advisoryAdmitted PatientsElectronic recordsWhite patientsAcute decompensated heart failure admissionsDecompensated heart failureLow ejection fractionHeart failure hospitalizationRe-HospitalizationAdmissionReadmissionConsultationEjection fractionElectronic health record nudges to optimize guideline-directed medical therapy for heart failure
Fuery M, Clark K, Sikand N, Tabtabai S, Sen S, Wilson F, Desai N, Ahmad T, Samsky M. Electronic health record nudges to optimize guideline-directed medical therapy for heart failure. Heart Failure Reviews 2025, 30: 771-776. PMID: 40106122, DOI: 10.1007/s10741-025-10503-4.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsElectronic health recordsClinical decision supportGuideline-directed medical therapyPotential of electronic health recordsElectronic health record systemsDiverse healthcare settingsGDMT adherenceCare qualityClinician workflowHealth recordsAlert contentHF careHealthcare settingsPatient careInformed treatment decisionsTargeted alertingQuality gapEnhanced usabilityImprove heart failureHeart failureDecision supportReal-timeCareTreatment decisionsAlerting strategy
2024
Cardiovascular Care in the United States Penny Wise and Pound Foolish
Ahmad T, Desai N, Tabtabai S. Cardiovascular Care in the United States Penny Wise and Pound Foolish. Journal Of The American College Of Cardiology 2024, 84: 694-695. PMID: 39142722, DOI: 10.1016/j.jacc.2024.07.001.Commentaries, Editorials and Letters
Academic Achievements & Community Involvement
Teaching & Mentoring
Mentoring
Marah Maayah, MD
Internal medicine resident2026 - PresentEman Mubarak
Internal medical resident2025 - PresentMaha Inam
Internal medical resident2025 - PresentEmma Barry
Yale Internal medical resident2024 - Present
Clinical Care
Overview
Sara Tabtabai, MD, is a cardiologist who specializes in heart failure and cardiovascular medicine. She diagnoses and treats conditions related to advanced heart failure, women's heart disease, cardio-obstetrics, and amyloid cardiomyopathy (where abnormal proteins accumulate in the heart muscle, leading to damage and impaired heart function).
As an assistant professor at Yale School of Medicine, Dr. Tabtabai is involved in research aimed at enhancing the understanding and treatment of heart failure.
Dr. Tabtabai earned her medical degree at the University of Connecticut School of Medicine. She then completed residency and fellowship training in internal and cardiovascular medicine, as well as advanced training in heart failure and transplantation, at Massachusetts General Hospital.
Clinical Specialties
Cardiovascular Medicine; Heart Failure
Fact Sheets
Cardiac Amyloidosis
Learn More on Yale MedicineAmyloidosis
Learn More on Yale MedicineHeart Disease in Women
Learn More on Yale MedicineHeart Transplant
Learn More on Yale Medicine
Board Certifications
Obesity Medicine
- Certification Organization
- AB of Obesity Medicine
- Original Certification Date
- 2025
Yale Medicine News
News
News
- June 29, 2026
Michael Nanna and Sara Tabtabai Join Yale Cardiovascular Medicine Fellowship Program Leadership Team
- May 13, 2026
Women As One Mentorship Awards Presented to Tabtabai and Alaiwi
- March 18, 2026
Advancing Research and Care To Improve Maternal Heart Health
- November 18, 2025
Upcoming Conference: Obesity and Genetic Heart Disease in the Era of Preventive Cardiology
Get In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.